Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

By Noveck Robert J.  

Clinical Pharmacokinetics, Vol. 46, Iss. 6, 2007-01 ,pp. : 525-534

Adis International

Access to resources Recommend Favorite

A single‐ and multiple‐dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 6, 2015-11 ,pp. : 418-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐ and Multiple‐Day Dosing Studies to Investigate High‐Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 33-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a Magnesium/Aluminium Hydroxide-Containing Antacid, Cimetidine or Ranitidine on the Pharmacokinetics of Metrifonate and its Metabolite DDVP

By Heinig R.  

Clinical Drug Investigation, Vol. 17, Iss. 1, 1999-01 ,pp. : 67-77

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan Medoxomil: In Healthy Volunteers and Hypertensive Patients

By Yoshihara Kazutaka  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1329-1342

Adis International

Access to resources Recommend Favorite